We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 81-100 of 10,000 results
  1. Maintenance of methylation profile in imprinting control regions in human induced pluripotent stem cells

    Background

    Parental imprinting is an epigenetic mechanism that leads to monoallelic expression of a subset of genes depending on their parental...

    A. Pham, C. Selenou, ... I. Netchine in Clinical Epigenetics
    Article Open access 28 December 2022
  2. Induction of Exaggerated Cytokine Production in Human Peripheral Blood Mononuclear Cells by a Recombinant SARS-CoV-2 Spike Glycoprotein S1 and Its Inhibition by Dexamethasone

    An understanding of the pathological inflammatory mechanisms involved in SARS-CoV-2 virus infection is necessary in order to discover new molecular...

    Olumayokun A. Olajide, Victoria U. Iwuanyanwu, ... Alaa A. Al-Hindawi in Inflammation
    Article Open access 16 April 2021
  3. The role of Nurr1-miR-30e-5p-NLRP3 axis in inflammation-mediated neurodegeneration: insights from mouse models and patients’ studies in Parkinson’s disease

    Nuclear receptor related-1 (Nurr1), a ligand-activated transcription factor, is considered a potential susceptibility gene for Parkinson’s disease...

    Tianbai Li, **ang Tan, ... Weidong Le in Journal of Neuroinflammation
    Article Open access 22 November 2023
  4. SARS-CoV-2 infection as a model to study the effect of cinnamaldehyde as adjuvant therapy for viral pneumonia

    Background

    The recent pandemic outbursts, due to SARS-CoV-2, have highlighted once more the central role of the inflammatory process in the...

    Bianca Vezzani, Mariasole Perrone, ... Carlotta Giorgi in Journal of Inflammation
    Article Open access 20 November 2023
  5. The Expression of MAFB Gene in Circulating Monocytes Is Related to Chronic Inflammatory Status in T2DM Patients

    Immune cell–mediated chronic inflammation is one of the causes of type 2 diabetes mellitus (T2DM). Therefore, identifying inflammatory markers in...

    Wanliang Zhang, Wenyun Chen, ... Ling Li in Inflammation
    Article 11 April 2024
  6. Progranulin haploinsufficiency mediates cytoplasmic TDP-43 aggregation with lysosomal abnormalities in human microglia

    Background

    Progranulin (PGRN) haploinsufficiency due to progranulin gene ( GRN ) variants can cause frontotemporal dementia (FTD) with aberrant TAR...

    Wonjae Sung, Min-Young Noh, ... Seung Hyun Kim in Journal of Neuroinflammation
    Article Open access 13 February 2024
  7. Biodistribution and immunity of adenovirus 5/35 and modified vaccinia Ankara vector vaccines against human immunodeficiency virus 1 clade C

    Previously, we developed a chimeric adenovirus type 5 with type 35 fiber (Ad5/35), which has high tropism to dendritic cells and low hepatoxicity....

    Masaru Shimada, Haibin Wang, ... Kenji Okuda in Gene Therapy
    Article 06 January 2022
  8. Attenuated Dengue virus PV001-DV induces oncolytic tumor cell death and potent immune responses

    Background

    Viral therapies developed for cancer treatment have classically prioritized direct oncolytic effects over their immune activating...

    Josef W. Goldufsky, Preston Daniels, ... Amanda L. Marzo in Journal of Translational Medicine
    Article Open access 19 July 2023
  9. Towards a better preclinical cancer model – human immune aging in humanized mice

    Background

    Preclinical models are often used for cancer studies and evaluation of novel therapeutics. The relevance of these models has vastly...

    Joel H. L. Tan, You Yi Hwang, ... Qingfeng Chen in Immunity & Ageing
    Article Open access 27 September 2023
  10. Immunosuppression by hydroxychloroquine: mechanistic proof in in vitro experiments but limited systemic activity in a randomized placebo-controlled clinical pharmacology study

    Based on its wide range of immunosuppressive properties, hydroxychloroquine (HCQ) is used for the treatment of several autoimmune diseases. Limited...

    Aliede E. in ‘t Veld, Hendrika W. Grievink, ... Matthijs Moerland in Immunologic Research
    Article Open access 22 February 2023
  11. The use of a systems approach to increase NAD+ in human participants

    Reversal or mitigation against an age-related decline in NAD + has likely benefits, and this premise has driven academic and commercial endeavour to...

    John D. Henderson, Sophia N. Z. Quigley, ... Dianne Ford in npj Aging
    Article Open access 01 February 2024
  12. Production of an interleukin-10 blocking antibody by genetically engineered macrophages increases cancer cell death in human gastrointestinal tumor slice cultures

    Although it can promote effector T-cell function, the summative effect of interleukin-10 (IL-10) in the tumor microenvironment (TME) appears to be...

    Kevin P. Labadie, Shannon A. Kreuser, ... Venu G. Pillarisetty in Cancer Gene Therapy
    Article 09 June 2023
  13. Zika virus infection suppresses CYP24A1 and CAMP expression in human monocytes

    Monocytes are the primary targets of Zika virus (ZIKV) and are associated with ZIKV pathogenesis. Currently, there is no effective treatment for ZIKV...

    Lady Johana Hernández-Sarmiento, Juan Felipe Valdés-López, Silvio Urcuqui-Inchima in Archives of Virology
    Article Open access 06 June 2024
  14. Reprogramming of Normal Cells into Human Pluripotent Stem Cells

    Human pluripotent stem cells (hPSCs) have the potential to become the source of materials for cell-based therapy. The similarity of hPSCs with the...
    Said M. Afify, Masaharu Seno in Methods in Cancer Stem Cell Biology
    Chapter 2023
  15. Rab37 mediates trafficking and membrane presentation of PD-1 to sustain T cell exhaustion in lung cancer

    Background

    Programmed cell death protein 1 (PD-1) is an immune checkpoint receptor expressed on the surface of T cells. High expression of PD-1 leads...

    Wan-Ting Kuo, I-Ying Kuo, ... Yi-Ching Wang in Journal of Biomedical Science
    Article Open access 07 February 2024
  16. A non-genetic engineering platform for rapidly generating and expanding cancer-specific armed T cells

    Background

    Cancer-specific adoptive T cell therapy has achieved successful milestones in multiple clinical treatments. However, the commercial...

    Yi-Jou Chen, Michael Chen, ... Kuo-Hsiang Chuang in Journal of Biomedical Science
    Article Open access 31 May 2023
  17. Biallelic human SHARPIN loss of function induces autoinflammation and immunodeficiency

    The linear ubiquitin assembly complex (LUBAC) consists of HOIP, HOIL-1 and SHARPIN and is essential for proper immune responses. Individuals with...

    Hirotsugu Oda, Kalpana Manthiram, ... Daniel L. Kastner in Nature Immunology
    Article 12 April 2024
  18. In Vitro Cytokine Production by Dengue-Infected Human Monocyte-Derived Dendritic Cells

    Despite many advances on the understanding of dengue pathogenesis in the last decades, some questions remained to be clarified. The virulence of the...
    Allan Henrique Depieri Cataneo, Juliano Bordignon, ... Guilherme Ferreira Silveira in Dengue Virus
    Protocol 2022
  19. How to Test Human CAR T Cells in Solid Tumors, the Next Frontier of CAR T Cell Therapy

    Chimeric antigen receptor (CAR) T cell therapy has proven to be a successful treatment option for leukemias and lymphomas. These encouraging outcomes...
    Russell W. Cochrane, Andrew Fiorentino, ... Leonardo M. R. Ferreira in Cancer Immunotherapy
    Protocol 2024
  20. 4-Octyl Itaconate Inhibits Proinflammatory Cytokine Production in Behcet’s Uveitis and Experimental Autoimmune Uveitis

    4-octyl itaconate (4-OI) is an anti-inflammatory metabolite that activates the nuclear-factor-E2-related factor 2 (NRF2) signaling. In the current...

    Qingfeng Wang, **ngsheng Ye, ... Peizeng Yang in Inflammation
    Article 06 January 2024
Did you find what you were looking for? Share feedback.